Corrigendum to “Development of African horse sickness disabled infectious single animal (DISA)-DIVA vaccine platform applied for all nine serotypes” [Vaccine 64 (2025) 127772]

Résumé fourni par la source

The acknowledgements section that was seen in the published version as. “We acknowledge excellent technical support by Erik van Weezep for in silico validation and Frank Harders for whole genome sequencing. This research has received funding from the Central Veterinary Research Laboratory, Dubai, UAE owned by His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and ruler of Dubai, (collaborative agreement 2200217/CRM-6017), from the European Union under the Horizon Europe Work Programme 2021-2022 ‘Food, Bioeconomy, Natural Resources, Agriculture and Environment’ under grant agreement no. 101059924 (SPIDVAC) and from the Dutch Ministry of Agriculture, Fishery, Food Safety and Nature (LVVN) (project WOT-01-002-041).” is being changed to. “We acknowledge excellent technical support by Erik van Weezep for in silico validation and Frank Harders for whole genome sequencing. This research has received funding from the Central Veterinary Research Laboratory, Dubai, UAE owned by His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and ruler of Dubai, (collaborative agreement 2200217/CRM-6017) and from the Dutch Ministry of Agriculture, Fishery, Food Safety and Nature (LVVN) (project WOT-01-002-041). Funded by the European Union under grant agreement 101059924 - SPIDVAC. Views and opinions expressed are however those of the authors only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them.” The authors would like to apologise for any inconvenience caused.